| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/30/2007 | CN1972921A 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
| 05/30/2007 | CN1972913A Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 05/30/2007 | CN1970557A Itraconazole mesylate and its composition and preparation method |
| 05/30/2007 | CN1970556A 1-furfuryl-3-substituted Indolinyl-2-one derivative, its preparation method and uses |
| 05/30/2007 | CN1970522A Production methods of epoxytriazole derivative and intermediate therefor |
| 05/30/2007 | CN1318417C Double ketole colorless benzofuryl ketone compound and its preparation |
| 05/30/2007 | CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/29/2007 | USRE39663 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes |
| 05/29/2007 | US7223863 Process for preparing Tadalafil and its intermediate |
| 05/29/2007 | US7223789 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/29/2007 | US7223788 therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders |
| 05/29/2007 | US7223785 Viral polymerase inhibitors |
| 05/29/2007 | US7223782 Pyrazole-amides and -sulfonamides |
| 05/29/2007 | US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets |
| 05/29/2007 | US7223776 Compounds with anti-bacterial activity |
| 05/29/2007 | US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 05/29/2007 | US7223757 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 05/29/2007 | US7223756 Treatment of autoimmune diseases, transplant rejection and rheumatoid arthritis with a quinazoline 4-substituted by a methylenedioxyphenyl group linked to the ring by an ether, methyl, sulfide, sulfoxide or sulfone, e.g., 6-methoxy-4-(2,3-methylenedioxyphenoxy)-7-(3-pyrrolidin-1-ylpropoxy)quinazoline, |
| 05/29/2007 | CA2258679C Solid solution of an antifungal agent with enhanced bioavailability |
| 05/24/2007 | WO2007059356A2 Furfurylidene- pyrazolidines and their use as inhibitors of ubiquitin e1 |
| 05/24/2007 | WO2007058602A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 05/24/2007 | WO2007058601A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia |
| 05/24/2007 | WO2007058392A1 Heterocyclic compound and medicinal application thereof |
| 05/24/2007 | WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/24/2007 | WO2007057742A2 Novel piperazinone derivatives |
| 05/24/2007 | WO2007037513A9 Aryl-substituted nitrogen-containing heterocyclic compound |
| 05/24/2007 | WO2007027527A3 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 05/24/2007 | WO2006042150A8 Diaminoalkane aspartic protease inhibitors |
| 05/24/2007 | US20070117990 Method of purifying dianhydrides |
| 05/24/2007 | US20070117858 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 05/24/2007 | US20070117850 substituted or unsubstituted 2-pyridyl moiety and a pyrozole ring substituted at 4 position with pyridine ring; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents |
| 05/24/2007 | US20070117845 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117836 Napthalimide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/24/2007 | US20070117818 Pyrimidinone compounds useful as kinase inhibitors |
| 05/24/2007 | US20070117817 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 05/24/2007 | US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 05/24/2007 | US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 05/24/2007 | US20070117795 Methods and compositions of novel triazine compounds |
| 05/24/2007 | US20070117758 Treating treating angiogenic disease, e.g., cancer, by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester |
| 05/24/2007 | DE102006006893B3 New aspoquinolone compounds useful in the preparation of anti-proliferative therapeutics |
| 05/24/2007 | CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia. |
| 05/24/2007 | CA2629514A1 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
| 05/23/2007 | EP1787985A1 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/23/2007 | EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 05/23/2007 | EP1786809A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 05/23/2007 | EP1786803A1 Pyrimidinylpyrazoles as tgf-beta inhibitors |
| 05/23/2007 | EP1786802A1 Pyrimidinylimidazoles as tgf-beta inhibitors |
| 05/23/2007 | EP1786801A1 Cytokine inhibitors |
| 05/23/2007 | EP1786773A1 Isoindolin-1-one derivatives |
| 05/23/2007 | EP1786770A1 N-(1-(2,3-dihydro-1h-inden-5yl) -2-oxo-3-pyrrolidinyl) -sulfonamide derivatives for use as factor xa inhibitors |
| 05/23/2007 | EP1786475A2 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 05/23/2007 | EP1786427A2 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/23/2007 | EP1585743B1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 05/23/2007 | EP1423384B1 Pyridine derivatives as raf kinase inhibitors |
| 05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | CN1968947A Heterocyclic condensed compounds useful as antidiuretic agents |
| 05/23/2007 | CN1968946A Benzimidazolone carboxylic acid derivatives |
| 05/23/2007 | CN1968945A Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| 05/23/2007 | CN1968937A Pyrimidin-4-one derivatives and their use as P38 kinase modulators |
| 05/23/2007 | CN1968929A Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 05/23/2007 | CN1966584A Sulfoxides or sulfones grafted onto polymers |
| 05/23/2007 | CN1966500A Quinoxaline derivative, preparation method and uses |
| 05/23/2007 | CN1966492A Sulfoxides or sulfones grafted onto polymers |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/23/2007 | CN1317277C Benzofuran derivatives and their use as antibacterial agents |
| 05/22/2007 | US7220868 Process for the preparation of novel dyes for use in imaging members |
| 05/22/2007 | US7220862 Calcitonin gene related peptide receptor antagonists |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
| 05/22/2007 | US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220770 preferably selectively inhibit cyclooxygenase-2 over cyclooxygenase-1; arthritis treament |
| 05/22/2007 | US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 05/22/2007 | US7220759 Isoquinoline compound and pharmaceutical use thereof |
| 05/22/2007 | US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders |
| 05/22/2007 | US7220746 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | US7220734 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists |
| 05/22/2007 | CA2436863C Process and ester derivatives useful for preparation of cephalosporins |
| 05/22/2007 | CA2266050C Piperazine derivatives |
| 05/22/2007 | CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
| 05/18/2007 | WO2007056596A2 Phosphoramidate derivatives of fau |
| 05/18/2007 | WO2007056341A1 Heterocyclic modulators of atp-binding cassette transporters |
| 05/18/2007 | WO2007056046A1 P2x7 receptor antagonists and methods of use |
| 05/18/2007 | WO2007055183A1 Benzene derivative or salt thereof |
| 05/18/2007 | WO2007054978A2 Process for preparing paroxetine hydrochloride hemihydrate |
| 05/18/2007 | WO2007054739A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 05/18/2007 | WO2007054470A1 Use of rylene derivatives as photosensitizers in solar cells |
| 05/18/2007 | WO2007054292A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/18/2007 | WO2007054128A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| 05/18/2007 | WO2007053869A2 Novel 2,2-dithiosubstituted furanose derivatives, method for the production and use thereof |
| 05/18/2007 | WO2007036715A3 Compounds which have activity at m1 receptor and their uses in medicine |
| 05/18/2007 | WO2007035841A9 Analogs of dehydrophenylahistins and their therapeutic use |
| 05/18/2007 | WO2007002635B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 05/18/2007 | WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |